Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Orian

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular & Cellular Oncology|February 16, 2017
Stabilization of nuclear oncoproteins by RNF4 and the ubiquitin system in cancerM Diefenbacher, A Orian
Science'S STKE : Signal Transduction Knowledge Environment|December 26, 2001
TGF-beta flips the Myc switchA Orian, R N Eisenman
The Journal of Biological Chemistry|May 15, 2001
Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domainS Cohen, A Orian, A Ciechanover
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 8, 2000
Ubiquitin-mediated proteolysis: biological regulation via destructionA Ciechanover, A Orian, A L Schwartz
Journal of Cellular Biochemistry. Supplement|April 13, 2000
The ubiquitin-mediated proteolytic pathway: mode of action and clinical implicationsA Ciechanover, A Orian, A L Schwartz
Molecular and Cellular Biology|December 1, 1995
Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymesI Stancovski, H Gonen, A Orian, et al.
Molecular and Cellular Biology|April 17, 1999
Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domainA Orian, A L Schwartz, A Israël, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathwayI Alkalay, A Yaron, A Hatzubai, et al.
The Journal of Biological Chemistry|September 15, 1995
Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugationA Orian, S Whiteside, A Israël, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1995
The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulatorsA Ciechanover, A Laszlo, B Bercovich, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Oncology|February 16, 2017
Stabilization of nuclear oncoproteins by RNF4 and the ubiquitin system in cancerM Diefenbacher, A Orian
Science'S STKE : Signal Transduction Knowledge Environment|December 26, 2001
TGF-beta flips the Myc switchA Orian, R N Eisenman
The Journal of Biological Chemistry|May 15, 2001
Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domainS Cohen, A Orian, A Ciechanover
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 8, 2000
Ubiquitin-mediated proteolysis: biological regulation via destructionA Ciechanover, A Orian, A L Schwartz
Journal of Cellular Biochemistry. Supplement|April 13, 2000
The ubiquitin-mediated proteolytic pathway: mode of action and clinical implicationsA Ciechanover, A Orian, A L Schwartz
Molecular and Cellular Biology|December 1, 1995
Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymesI Stancovski, H Gonen, A Orian, et al.
Molecular and Cellular Biology|April 17, 1999
Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domainA Orian, A L Schwartz, A Israël, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathwayI Alkalay, A Yaron, A Hatzubai, et al.
The Journal of Biological Chemistry|September 15, 1995
Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugationA Orian, S Whiteside, A Israël, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1995
The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulatorsA Ciechanover, A Laszlo, B Bercovich, et al.
Pageof 2